Michael D Stein1, Micah T Conti2, Shannon Kenney3, Bradley J Anderson4, Jessica N Flori5, Megan M Risi6, Genie L Bailey7. 1. Behavioral Medicine, Butler Hospital, Providence, RI, 02906, USA; Boston University School of Public Health, Boston, MA, 02118, USA. Electronic address: mdstein@bu.edu. 2. Behavioral Medicine, Butler Hospital, Providence, RI, 02906, USA; Stanley Street Treatment and Resources, Inc., Fall River, MA, 02720, USA. Electronic address: mconti@sstar.org. 3. Behavioral Medicine, Butler Hospital, Providence, RI, 02906, USA; Warren Alpert Medical School of Brown University, Providence, RI, 02912, USA. Electronic address: Shannon_Kenney@Brown.edu. 4. Behavioral Medicine, Butler Hospital, Providence, RI, 02906, USA. Electronic address: bjanderson@butler.org. 5. Behavioral Medicine, Butler Hospital, Providence, RI, 02906, USA; Stanley Street Treatment and Resources, Inc., Fall River, MA, 02720, USA. Electronic address: jflori@sstar.org. 6. Behavioral Medicine, Butler Hospital, Providence, RI, 02906, USA; Stanley Street Treatment and Resources, Inc., Fall River, MA, 02720, USA. Electronic address: mrisi@sstar.org. 7. Stanley Street Treatment and Resources, Inc., Fall River, MA, 02720, USA; Warren Alpert Medical School of Brown University, Providence, RI, 02912, USA. Electronic address: genie_bailey@brown.edu.
Abstract
INTRODUCTION: Adverse childhood experiences are associated with the development of substance use disorders. With opioid use disorder, a growing concern in the United States, we were interested in examining the relationship between adverse experiences and three landmarks of opioid use: age of opioid initiation, injection drug use, and lifetime overdose. METHODS: Between May and December 2015, we interviewed consecutive persons seeking inpatient opioid detoxification. Participants were asked about age of opioid initiation, last month injection drug use, and lifetime history of overdose, and completed the ten-item Adverse Childhood Experience (ACE) questionnaire. RESULTS: Participants (n=457) averaged 32.2 (±8.64) years of age, 71.3% were male, and 82.5% were non-Hispanic White. The mean score on the ACE scale was 3.64 (±2.75). Mean age at time of initiating opioid use was 21.7 (±7.1) years, 68.7% had injected drugs within the past month, and 39.0% had overdosed. After adjusting for age, gender, and ethnicity, the ACE score was inversely associated with age of initiating opioid use (b=-0.50, 95% CI -0.70; -0.29, p<.001), and positively associated with recent injection drug use (OR=1.11, 95% CI 1.02; 1.20, p=0.014) and the likelihood of experiencing an overdose (OR=1.10, 95% CI 1.02; 1.20, p=0.015) in a graded dose response manner. CONCLUSION: Greater adverse childhood experiences are associated with three landmarks of opioid use risk. ACE screening may be useful in identifying high-risk subsets of opioid-using populations.
INTRODUCTION: Adverse childhood experiences are associated with the development of substance use disorders. With opioid use disorder, a growing concern in the United States, we were interested in examining the relationship between adverse experiences and three landmarks of opioid use: age of opioid initiation, injection drug use, and lifetime overdose. METHODS: Between May and December 2015, we interviewed consecutive persons seeking inpatient opioid detoxification. Participants were asked about age of opioid initiation, last month injection drug use, and lifetime history of overdose, and completed the ten-item Adverse Childhood Experience (ACE) questionnaire. RESULTS:Participants (n=457) averaged 32.2 (±8.64) years of age, 71.3% were male, and 82.5% were non-Hispanic White. The mean score on the ACE scale was 3.64 (±2.75). Mean age at time of initiating opioid use was 21.7 (±7.1) years, 68.7% had injected drugs within the past month, and 39.0% had overdosed. After adjusting for age, gender, and ethnicity, the ACE score was inversely associated with age of initiating opioid use (b=-0.50, 95% CI -0.70; -0.29, p<.001), and positively associated with recent injection drug use (OR=1.11, 95% CI 1.02; 1.20, p=0.014) and the likelihood of experiencing an overdose (OR=1.10, 95% CI 1.02; 1.20, p=0.015) in a graded dose response manner. CONCLUSION: Greater adverse childhood experiences are associated with three landmarks of opioid use risk. ACE screening may be useful in identifying high-risk subsets of opioid-using populations.
Authors: Maxia Dong; Robert F Anda; Vincent J Felitti; Shanta R Dube; David F Williamson; Theodore J Thompson; Clifton M Loo; Wayne H Giles Journal: Child Abuse Negl Date: 2004-07
Authors: Maxia Dong; Wayne H Giles; Vincent J Felitti; Shanta R Dube; Janice E Williams; Daniel P Chapman; Robert F Anda Journal: Circulation Date: 2004-09-20 Impact factor: 29.690
Authors: Shanta R Dube; Vincent J Felitti; Maxia Dong; Daniel P Chapman; Wayne H Giles; Robert F Anda Journal: Pediatrics Date: 2003-03 Impact factor: 7.124
Authors: Robert F Anda; Charles L Whitfield; Vincent J Felitti; Daniel Chapman; Valerie J Edwards; Shanta R Dube; David F Williamson Journal: Psychiatr Serv Date: 2002-08 Impact factor: 3.084
Authors: Daniel P Chapman; Charles L Whitfield; Vincent J Felitti; Shanta R Dube; Valerie J Edwards; Robert F Anda Journal: J Affect Disord Date: 2004-10-15 Impact factor: 4.839
Authors: Shanta R Dube; Robert F Anda; Vincent J Felitti; Valerie J Edwards; Janet B Croft Journal: Addict Behav Date: 2002 Sep-Oct Impact factor: 3.913
Authors: Elizabeth A Swedo; Steven A Sumner; Sietske de Fijter; Luke Werhan; Kirkland Norris; Jennifer L Beauregard; Martha P Montgomery; Erica B Rose; Susan D Hillis; Greta M Massetti Journal: J Pediatr Date: 2020-05-11 Impact factor: 4.406
Authors: Erin L Winstanley; James J Mahoney; Laura R Lander; James H Berry; Patrick Marshalek; Wanhong Zheng; Marc W Haut Journal: J Subst Abuse Treat Date: 2020-06-05
Authors: Hilary S Connery; Nadine Taghian; Jungjin Kim; Margaret Griffin; Ian R H Rockett; Roger D Weiss; R Kathryn McHugh Journal: Drug Alcohol Depend Date: 2019-10-05 Impact factor: 4.492